Rchr
J-GLOBAL ID：200901061421615958
Update date: Aug. 28, 2024
Kusumoto Shigeru
クスモト シゲル | Kusumoto Shigeru
Affiliation and department：
Job title：
Chief
Research field (1)：
Hematology and oncology
Research keywords (4)：
悪性リンパ腫
, Hematopoietic stem cell transplantation
, HBV再活性化
, 多発性骨髄腫
Research theme for competitive and other funds (4)：
- 2020 - 2023 がん化学療法後のB型肝炎ウイルス再活性化後の核酸アナログ中止規準の確立
- 2016 - 2020 Elucidation of mechanism of HBV reactivation associated with mogamulizumab-containing chemotherapy
- 2012 - 2015 Risk factor and mechanism of reactivation of hepatitis B virus following systemic chemotherapy
- 2008 - 2010 Identification of effective supportive care for cancer patients undergoing chemotherapy on evidence-based QOL assessment
Papers (196)：
-
Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi, Hiroaki Onaya, Masahiko Oguchi, Shinsuke Iida, Kisato Nosaka, Yasuhiro Suzuki, Yasuhiko Harada, et al. Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305). Cancer Science. 2024
-
Takuto Tachita, Masaki Ri, Sho Aoki, Arisa Asano, Takashi Kanamori, Haruhito Totani, Shiori Kinoshita, Yu Asao, Tomoko Narita, Ayako Masaki, et al. Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone. Cancer Medicine. 2024
-
Takahiro Nakashima, Shigeru Kusumoto, Takashi Ishida, Chie Kato, Shinya Hagiwara, Tomoko Narita, Ayako Masaki, Asahi Ito, Masaki Ri, Hirokazu Komatsu, et al. Fulminant hepatitis in a hepatitis B surface antigen-positive patient with adult T-cell leukemia-lymphoma after mogamulizumab monotherapy. Hepatology Research. 2024
-
Keiichiro Fujii, Atsushi Inagaki, Ayako Masaki, Mariko Sugiura, Tomotaka Suzuki, Takashi Ishida, Shigeru Kusumoto, Shinsuke Iida, Hiroshi Inagaki. Nomogram for predicting survival of patients with diffuse large B-cell lymphoma. Annals of hematology. 2024
-
Masahiro Onozawa, Shigeru Kusumoto, Yuho Najima, Hiroya Hashimoto, Kohei Okada, Masaharu Tamaki, Masatsugu Tanaka, Takayuki Sato, Tsutomu Takahashi, Kaoru Hatano, et al. Outcomes of cessation of the administration of nucleos(t)ide analogues on HBV reactivation after allogeneic hematopoietic stem cell transplantation: A nationwide retrospective study. Transplantation and cellular therapy. 2024
ｍore...
MISC (65)：
-
萩原宏美, 中山貴文, 橋本大哉, 楠本茂, 福田英克, 神谷武, 飯田真介. Risk factors associated with overall survival after carfilzomib in multiple myeloma patients: A retrospective study using a Japanese claims database. 日本薬学会年会要旨集(Web). 2023. 143rd
-
萩原宏美, 萩原宏美, 中山貴文, 橋本大哉, 楠本茂, 福田英克, 神谷武, 神谷武, 飯田真介. 再発又は難治性多発性骨髄腫患者におけるプロテアソーム阻害剤カルフィルゾミブ投与時の生存期間に影響を与えるリスク因子の探索. 日本臨床腫瘍薬学会雑誌(Web). 2023. 30
-
Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, et al. Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study). BLOOD. 2022. 140. 11890-11892
-
丸山 大, 鏡味 良豊, 柴田 大朗, 飛内 賢正, 山本 一仁, 今泉 芳孝, 内田 俊樹, 島田 和之, 皆内 康一郎, 福原 規子, et al. 大量化療前導入治療R-CHOP-14とR-CHOP-14/CHASERの比較試験 JCOG0908(R-CHOP-14 vs. R-CHOP-14/CHASER induction prior to HDT in poor-risk untreated DLBCL: JCOG0908). 臨床血液. 2018. 59. 9. 1556-1556
-
飯田 真介, 丸山 大, 小川 岳人, 楠本 茂, 福原 傑, 福原 規子, 瀬尾 幸子, 宮崎 香奈, 吉満 誠, 黒田 純也, et al. 未治療移植非適応多発性骨髄腫に対するMPB療法変法のランダム化第II相試験(JCOG 1105)(Randomized phase II study to optimize MPB in untreated transplant-ineligible myeloma: JCOG1105). 臨床血液. 2018. 59. 9. 1610-1610
ｍore...
Education (1)：
Return to Previous Page
